The Lancet thelancet.com

[Comment] Global tuberculosis response off track: urgent priorities to end the world's top infectious killer

thelancet.com·23w

[Articles] Zoliflodacin versus ceftriaxone plus azithromycin for treatment of uncomplicated urogenital gonorrhoea: an international, randomised, controlled, ope...

thelancet.com·23w

[Correspondence] Russia's health workers complicit in abducting Ukraine's children

thelancet.com·23w

[Correspondence] Darfur's humanitarian emergency: a call for immediate action

thelancet.com·23w

[Comment] Zoliflodacin shows benefit as an oral treatment for uncomplicated gonorrhoea

thelancet.com·23w

[Articles] Disease burden attributable to intimate partner violence against females and sexual violence against children in 204 countries and territories, 1990–...

thelancet.com·23w

[Comment] A step forward in the treatment of relapsed or refractory follicular lymphoma

thelancet.com·23w

[Articles] Epcoritamab, lenalidomide, and rituximab versus lenalidomide and rituximab for relapsed or refractory follicular lymphoma (EPCORE FL-1): a global, op...

thelancet.com·23w

[Articles] Tafasitamab, lenalidomide, and rituximab in relapsed or refractory follicular lymphoma (inMIND): a global, phase 3, randomised controlled trial

thelancet.com·24w

[Comment] A new standard for relapsed or refractory follicular lymphoma

thelancet.com·24w

[Comment] Reducing term pre-eclampsia by 30%: is it possible?

thelancet.com·24w

[Articles] Scheduled birth at term for the prevention of pre-eclampsia (PREVENT-PE): an open-label randomised controlled trial

thelancet.com·24w

[Correspondence] Research in health-care resilience for large-scale conflict

thelancet.com·24w

[World Report] Aid cuts hampering Nepal's tuberculosis care

thelancet.com·24w

[Comment] The Lancet Commission on the Future of Ukraine's Health System

thelancet.com·24w

[Comment] Legitimate expectations and the abrupt cessation of US aid: a human rights issue?

thelancet.com·24w

[Perspectives] James D Watson: a cautionary tale

thelancet.com·24w

[Comment] Lancet Commission on Health Systems Performance Assessment

thelancet.com·24w

[Perspectives] James D Watson: a cautionary tale

thelancet.com·24w

[Comment] Lancet Commission on Health Systems Performance Assessment

thelancet.com·24w

Log in to enable infinite scrolling